About Ilan Oren
Ilan Oren is a director at Roivant Sciences.
Form D filings name Ilan Oren as a director at Kriya Therapeutics.
Ilan Oren reports to the SEC as a director or major shareholder of 2 public companies, including Sio Gene Therapies (SIOX).
Ilan Oren first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Ilan Oren in the role, so the role may have started earlier or lasted longer.
RL
Roivant Sciences Ltd.
Director
2021 – 2026 · Public company (ROIV)
SI
Sio Gene Therapies Inc.
Director and 10% owner
2015 – 2018 · Public company (SIOX)
Key Colleagues at Startups
The people Ilan Oren works with at each company, as listed on that company's latest Form D.
Kriya Therapeutics, Inc. · Form D/A, Sep 10, 2025
NV
Neelaksh Varshney
Director
MS
Michele Stone
Executive officer
SR
Saira Ramasastry
Director
RG
Ryan Gallagher
Director
KM
Keith Manchester
Director
KE
Katherine Eade
Executive officer
JM
James Momtazee
Director
AR
Akshay Rai
Director
SR
Shankar Ramaswamy
Chief Executive Officer and director
CH
Curt Herberts
Executive officer
BP
Britt Petty
Executive officer
RJ
Roger Jeffs
Director
BF
Brian Furmanski
Executive officer
TG
Trit Garg
Director